The Efficacy and Safety of Ferriprox for the Treatment of Transfusional Iron Overload in Patients With Sickle Cell Disease or Other Anaemias
Phase of Trial: Phase IV
Latest Information Update: 06 Mar 2018
At a glance
- Drugs Deferiprone (Primary) ; Deferoxamine
- Indications Iron overload
- Focus Therapeutic Use
- Acronyms FIRST
- Sponsors ApoPharma
- 10 Jun 2017 Biomarkers information updated
- 10 Mar 2017 Planned End Date changed from 1 Mar 2017 to 1 Sep 2019.
- 10 Mar 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Sep 2019.